NCT00533767

Brief Summary

This study is designed to evaluate the transmission of hantavirus in Chile. It is an observational study that will look at close household contacts of people who have been diagnosed with hantavirus infections that result in a serious illness to see how frequently they become infected. Subjects who enroll in the study will donate samples of body fluids (e.g., blood, saliva, stool, urine, respiratory and vaginal secretions) to allow the researchers to see if hantavirus is present in those fluids and if so, how much. Subjects will also be interviewed to identify household conditions that may be associated with transmission. Up to 76 index cases (people who are first diagnosed with hantavirus cadiopulmonary illness) and up to 140 of their close contacts will be enrolled. Subjects will be followed for about 6 weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
197

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 21, 2007

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

January 10, 2024

Status Verified

January 1, 2024

Enrollment Period

6.6 years

First QC Date

September 20, 2007

Last Update Submit

January 8, 2024

Conditions

Keywords

Hantavirus cardiopulmonary syndrome, Andes virus, Chile

Outcome Measures

Primary Outcomes (1)

  • Estimate the secondary attack rate among close household contacts of index cases with hantavirus cardiopulmonary syndrome in Chile

    35 days

Secondary Outcomes (1)

  • Determine the quantity of hantavirus in bodily fluids in persons with hantavirus infection

    35 days

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

76 index cases with hantavirus cardiopulmonary syndrome and their close household contacts

You may qualify if:

  • Index Cases:
  • Confirmed diagnosis, positive hantavirus IgM assay or detection of hantavirus in plasma or serum by RT-PCR.
  • Signed informed consent form.
  • Less than 96 hours have transpired since the diagnosis was confirmed.
  • Household Contact
  • Any person, 2 years of age or older, who has been in close contact with the index case at any point from 30 days before to 7 days after the onset of symptoms in the index case.
  • Close contact must include: sexual contact and/or deep kissing and/or slept in same bed and/or provided direct care to index case.

You may not qualify if:

  • Index Cases
  • Index case does not have or agree to give the names of his/her close contacts.
  • Not a suitable candidate in the opinion of the investigator.
  • Household Contact
  • Confirmed current or previous infection with Andes virus.
  • Younger than 2 years of age.
  • Unavailable for follow up or not a suitable candidate in the opinion of the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Catolica de Chile

Santiago, Chile

Location

MeSH Terms

Conditions

Hantavirus Infections

Condition Hierarchy (Ancestors)

Bunyaviridae InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Gregory Mertz, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2007

First Posted

September 21, 2007

Study Start

July 1, 2007

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

January 10, 2024

Record last verified: 2024-01

Locations